U.S. market Closed. Opens in 7 hours 57 minutes

VACC | Vaccitech plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
Revenue44.70M268.00K4.82M6.85M
Cost of Revenue42.35M20.37M14.39M29.84M
Gross Profit2.35M-20.10M-9.57M-23.00M
Operating Expenses47.50M41.49M21.59M391.96K
Selling, General & Admin6.39M25.12M10.48M2.67M
Research & Development41.11M16.37M11.11M29.84M
Other Operating Expenses567.00K332.00K41.69KN/A
Operating Income-3.45M-45.22M-20.05M-22.69M
Other Expenses / Income4.30M-5.92M2.21M-9.10K
Before Tax Income850.00K-51.14M-17.84M-22.70M
Income Tax Expenses-4.47M-28.00K95.01K-1.97M
Net Income5.34M-51.11M-17.93M-20.73M
Interest Expenses19.00K2.67M3.60MN/A
Basic Shares Outstanding37.25M25.89M7.90M23.47K
Diluted Shares Outstanding38.17M25.89M7.90M23.47K
EBITDA869.00K-40.89M-16.52M-22.52M
EBITDA Margin1.94%-15,255.97%-342.67%-329.01%
EBIT890.00K-48.47M-14.24M-22.70M
EBIT Margin1.99%-18,086.57%-295.40%-331.60%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙